142 related articles for article (PubMed ID: 30530006)
21. Improved bioavailability and anticancer efficacy of Hesperetin on breast cancer via a self-assembled rebaudioside A nanomicelles system.
Wang J; Li Q; Chen Z; Qi X; Wu X; Di G; Fan J; Guo C
Toxicol Appl Pharmacol; 2021 May; 419():115511. PubMed ID: 33819459
[TBL] [Abstract][Full Text] [Related]
22. Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles.
Yuan X; Xie Q; Su K; Li Z; Dong D; Wu B
Int J Nanomedicine; 2017; 12():4981-4989. PubMed ID: 28761339
[TBL] [Abstract][Full Text] [Related]
23. Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.
Liu Y; Xu Y; Wu M; Fan L; He C; Wan JB; Li P; Chen M; Li H
Int J Nanomedicine; 2016; 11():3167-78. PubMed ID: 27471384
[TBL] [Abstract][Full Text] [Related]
24. Inulin-pluronic-stearic acid based double folded nanomicelles for pH-responsive delivery of resveratrol.
Jangid AK; Patel K; Jain P; Patel S; Gupta N; Pooja D; Kulhari H
Carbohydr Polym; 2020 Nov; 247():116730. PubMed ID: 32829852
[TBL] [Abstract][Full Text] [Related]
25. One-step self-assembled nanomicelles for improving the oral bioavailability of nimodipine.
Luo JW; Zhang ZR; Gong T; Fu Y
Int J Nanomedicine; 2016; 11():1051-65. PubMed ID: 27042060
[TBL] [Abstract][Full Text] [Related]
26. Assessment of cell viability and permeation enhancement in presence of lipid-based self-emulsifying drug delivery systems using Caco-2 cell model: Polysorbate 80 as the surfactant.
Bu P; Ji Y; Narayanan S; Dalrymple D; Cheng X; Serajuddin AT
Eur J Pharm Sci; 2017 Mar; 99():350-360. PubMed ID: 28024890
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxic effect of novel Flammulina velutipes sterols and its oral bioavailability via mixed micellar nanoformulation.
Yi C; Sun C; Tong S; Cao X; Feng Y; Firempong CK; Jiang X; Xu X; Yu J
Int J Pharm; 2013 May; 448(1):44-50. PubMed ID: 23524118
[TBL] [Abstract][Full Text] [Related]
28. PLGA-PEG-PLGA triblock copolymeric micelles as oral drug delivery system: In vitro drug release and in vivo pharmacokinetics assessment.
Chen X; Chen J; Li B; Yang X; Zeng R; Liu Y; Li T; Ho RJY; Shao J
J Colloid Interface Sci; 2017 Mar; 490():542-552. PubMed ID: 27923139
[TBL] [Abstract][Full Text] [Related]
29. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
Lima BDS; Campos CA; da Silva Santos ACR; Santos VCN; Trindade GDGG; Shanmugam S; Pereira EWM; Marreto RN; Duarte MC; Almeida JRGDS; Quintans JSS; Quintans LJ; Araújo AAS
Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
[TBL] [Abstract][Full Text] [Related]
30. Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy.
Cunha C; Marinheiro D; Ferreira BJML; Oliveira H; Daniel-da-Silva AL
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375331
[TBL] [Abstract][Full Text] [Related]
31. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
[TBL] [Abstract][Full Text] [Related]
32. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
Zhang X; Wang H; Zhang T; Zhou X; Wu B
Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461
[TBL] [Abstract][Full Text] [Related]
33. Improved oral bioavailability of magnolol by using a binary mixed micelle system.
Ding P; Shen H; Wang J; Ju J
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):668-674. PubMed ID: 30183380
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer's disease.
Sharma D; Singh M; Kumar P; Vikram V; Mishra N
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1620-1630. PubMed ID: 28102083
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of oral bioavailability of magnolol by encapsulation in mixed micelles containing pluronic F127 and L61.
Shen H; Liu S; Ding P; Wang L; Ju J; Liang G
J Pharm Pharmacol; 2018 Apr; 70(4):498-506. PubMed ID: 29433156
[TBL] [Abstract][Full Text] [Related]
36. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.
Shen J; Bi J; Tian H; Jin Y; Wang Y; Yang X; Yang Z; Kou J; Li F
Int J Nanomedicine; 2016; 11():4919-4929. PubMed ID: 27713630
[TBL] [Abstract][Full Text] [Related]
38. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
[TBL] [Abstract][Full Text] [Related]
39. Development and characterization of self-assembling lecithin-based mixed polymeric micelles containing quercetin in cancer treatment and an in vivo pharmacokinetic study.
Chen LC; Chen YC; Su CY; Hong CS; Ho HO; Sheu MT
Int J Nanomedicine; 2016; 11():1557-66. PubMed ID: 27143878
[TBL] [Abstract][Full Text] [Related]
40. Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation.
Zhang HY; Sun CY; Adu-Frimpong M; Yu JN; Xu XM
Int J Pharm; 2019 Jan; 555():270-279. PubMed ID: 30471374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
